Actively Recruiting
PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic Disease
Led by Columbia University · Updated on 2026-04-02
1000
Participants Needed
1
Research Sites
1378 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The specific aims of this project are to create a registry, as well as a biospecimen bank for individuals with pancreatic disease (e.g. pancreatic adenocarcinoma, pancreatitis, intraductal papillary mucinous neoplasm (IPMN) mucinous cystic neoplasm (MCN), and pancreatic intraepithelial neoplasia (PanIN) or have been determined to be at high-risk for pancreatic cancer. Biospecimen can be defined as blood, urine, tissue, stool, or saliva samples. Therefore, no hypothesis is to be tested. The personal data derived from the registry, correlated with biological information derived from the biospecimens will allow for future investigative studies of pancreatic cancer etiology and tumor biology. The long-term goals of the study are to advance the knowledge of the etiology and epidemiology of pancreatic cancer. It is anticipated that the knowledge derived will ultimately lead to improvements in the diagnosis, prevention, detection,and treatment of pancreatic cancer.
CONDITIONS
Official Title
PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Individuals diagnosed with pancreatic cancer or suspected pancreatic cancer, or with a pre-neoplastic pancreatic lesion, aged 18 years or older
- Individuals 18 years or older identified as high risk for pancreatic cancer based on clinical criteria such as hereditary nonpolyposis colorectal cancer (HNPCC) or other hereditary cancer syndromes
- Individuals with personal or family history of pancreatic cancer-associated syndromes including Peutz-Jeghers syndrome, familial pancreatic cancer syndrome, BRCA1 or BRCA2 related breast cancer syndrome, hereditary pancreatitis, familial atypical multiple mole melanoma, and others
- Patients from families with genetically determined cancer predisposition syndromes
- Patients with a personal history of gastrointestinal cancer diagnosed before age 45
- Individuals with high risk based on personal or family history not related to known pancreatic cancer syndromes, including multiple family members with cancer or early onset gastrointestinal cancers
You will not qualify if you...
- Unable to provide informed consent for study enrollment
- Under 18 years old
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Columbia University Medical Center
New York, New York, United States, 10032
Actively Recruiting
Research Team
V
Vilma Rosario
CONTACT
B
Beth Schrope, MD, PhD, FACS
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here